SGO 2022 Conference Coverage on VuMedi


 

SGO 2022 Phase II Trial of Maintenance Niraparib in Stage III/IV or Platinum-Sensitive Recurrent Uterine Serous Carcinoma

203 views
April 7, 2022
Comments 0
Login to view comments. Click here to Login